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Prenatal Diagnosis of Neural Tube Defects
J. N. Macri, D. A. Baker
The embryonic forerunner of the human central nervous System is the
neural tube, a structure which achieves tubular form prior to the 30th
day of pregnancy.l It is believed that failure of normal tubular devel-
opment in the primordial head region leads to anencephaly while a similar
incident along the developing spinal cord results in one of the varying
forms of spina bifida.
The use of alpha-fetoprotein (AFP) s a biochemical marker to aid in the
prenatal detection of neural tube defect (NTD) was first introduced in
the early 1970's and is currently most often applied to three specific
pregnancy subgroups.^'3 Families with a history of NTD may elect to un-
dergo genetic counseling, diagnostic ultrasound, amniocentesis, and am-
niotic fluid alpha-fetoprotein (AFAFP) evaluation. Mothers with no his-
tory of congenital malformations may participate in maternal serum alpha-
fetoprotein (MSAFP) screening which may lead to the clinical evaluations
indicated in families with an NTD history. Finally, pregnancies undergo-
ing genetic amniocentesis for other reasons may elect to have AFAFP eval-
uation to rule out open NTD. This report presents results relating spec-
ifically to the above three pregnancy subgroups.
Population A - Increased Risk Because of History of NTD
Nine hundred and ten pregnancies under evaluation were considered at in-
creased risk for NTD because of the previous birth of an affected child
or the existence of an affected first degree relative (Table I) .
All 16 fetuses with open
Open NTD [AFAFP > 5 S.D. Above Meanl ΜΙΤ1Τ^ -. . . , ,„._ nAnencephaly 9 NTD demonstrated AFAFP lev-
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Table I and AFAFP levels and repre-
sented the only false-nega-
tive result. No false-positive result leading to the termination of a
normal fetus occurred. Of the other malformations noted only encephalo-
cele was diagnosed prenatally.
Seven pregnancies with normal fetal outcome demonstrated AFAFP levels
greater than 3 Standard deviations above the mean. Five feil between 3
and 5 Standard deviations, and 2 more than 5 Standard deviations above
the mean; 3 of the former samples and both of the latter were contami-
nated by fetal blood. All seven proceed to term on the basis of normal
ultrasound and/or amniography.
Population B - Increased Risk Because of MSAFP Elevation
The Long Island regional AFP screening project identified 365 of 17,703
unselected pregnancies (2.1%) with an indication for further clinical
evaluation. Twenty fetuses with NTD were detected (Table II) , nineteen
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of which demonstrated AFAFP levels greater than 5 Standard deviations
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case of open spina bifida
open NTD showed AFAFP levels be^
»(i^^TJIL~::™Z^-~-Z==: II tween 3 and 5 Standard
_________________________________________________ 3 deviations above the mean.
Omphalocele ---- ..... ------------ ....... ------ ..... ---------- *
Band ----------------------------------------------- i Gastroschisis , omphalocele
Congenital Nephrosis ------------- ...... ----------- -̂  ---------- *
.. ...... _______ ....... __________________ .- _______ * and amniotic band
•  —  drome also were diagnosed.
Congenital nephrosis and
Table II microcephaly both were
assöciated with signifi-
cant elevations in MSAFP and AFAFP levels/ but detailed ultrasound eval-
uation and amniography revealed no NTD; these pregnancies continued to
term.
Eight pregnancies of the amniocentesis group of 365 demonstrated elevated
MSAFP and AFAFP levels and normal fetal outcome; all 8 had AFAFP sämples
between 3 and 5 Standard deviations above the mean. Föur of the 8 säm-
ples were contaminated by fetal blood. All 8 proceeded to term, äs vis-
ualization showed no fetal abnormality.
Within the group receiving amniocentesis, no false-positive amniotic
fluid results have led to the terminatiön of 'a normal fetus, and no
false-negative results have been observed. Of the total screened popula^-
tion of 17,703, the screening process has demonstrated an overall sensi-
tivity of 91%.
Population C - Increased Risk for Reasons Other Than NTD History or MSAFP
Six thousand five hundred and four pregnancies considered at increased
risk for reasons other than history of NTD or elevated MSAFP levels have
been evaluated. Of this study population, 22 fetuses with NTD had AFAFP
levels greater than 5 Standard deviations above the mean (Table III) ,
[AFAFP level > 5 S.D. above mean] A Single Skin COVered NTD
had normal MSAFP and AF-
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_ "" normal fetus.
Table III of ^ 12 other malforma-
tions within this group,
the following were diagnosed prenatally: encephalocele (4) , omphalocele
( 4 ) , cyclopis (1), and congenital nephosis (1). in this case of congeni-
tal nephrosis, the family was at significant risk for recurrence. In
spite of a normal ultraso"und study, the family chose terminatiön of the
pregnancy on the basis of biochemical results. Post-mortem evaluation of
the fetus confirmed the diagnosis.
Among the 6,504 pregnancies evaluated, 37 without fetal malformations had
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AFAFP levels greater than 3 Standard deviations above the mean. Of 30
samples showing AFAFP levels between 3 and 5 Standard deviations above
the mean/ 11 were contaminated with fetal blood. All 30 pregnancies pro-
ceeded to term on the basis of fetal visualization by ultrasound and/or
amniography. Of 7 samples with AFAFP levels greater than 5 Standard dev-
iations above the mean, 6 were contaminated by fetal blood. Of 6,504
pregnancies evaluated, one demonstrated an unexplainable AFAFP evaluation.
This pregnancy continued to term on the basis of normal fetal visualiza-
tion.
Conclusion
It would appear that a large body of Information has accumulated support-
ing a rapid expansion of MSAFP screening and testing. Our views on this
possibility äs well äs our specific recommendations for AFP program de-
velopment have recently appeared.^'^ We do not believe that rapid expan-
sion toward nationwide screening within the obstetrical practicö patterns
characteristic of the United States will be a practical or safe means of
proceeding. We do believe that AFP testing should be developed regionally
on a pilot program basis to insure proper interprofessional communica-
tions, quality control, access to all needed clinical evaluations and in
turn safe and effective testing. With proper program design and Implemen-
tation, AFP screening and testing can be an important addition to prenatal
care.
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